Berger R - Search Results

1

Intranasal interferon for contact prophylaxis against common cold in families.

Herzog C, Just M, Berger R, Havas L, Fernex M. Herzog C, et al. Among authors: berger r. Lancet. 1983 Oct 22;2(8356):962. doi: 10.1016/s0140-6736(83)90470-1. Lancet. 1983. PMID: 6138515 Clinical Trial. No abstract available.

2

What dose of intranasal interferon for the common cold?

Herzog C, Berger R, Fernex M, Friesecke K, Havas L, Just M, Dubach UC. Herzog C, et al. Among authors: berger r. Lancet. 1986 May 10;1(8489):1089-90. doi: 10.1016/s0140-6736(86)91350-4. Lancet. 1986. PMID: 2871352 Clinical Trial. No abstract available.

3

Intranasal interferon (rIFN-alpha A, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled field study.

Herzog C, Berger R, Fernex M, Friesecke K, Havas L, Just M, Dubach UC. Herzog C, et al. Among authors: berger r. Antiviral Res. 1986 May;6(3):171-6. doi: 10.1016/0166-3542(86)90011-2. Antiviral Res. 1986. PMID: 3524441 Clinical Trial.

4

Measles vaccination in early infancy.

Berger R, Just M, Glück R, Grassi M, Wegmann A. Berger R, et al. Lancet. 1990 Mar 3;335(8688):540. doi: 10.1016/0140-6736(90)90773-x. Lancet. 1990. PMID: 1968549 Clinical Trial. No abstract available.

5

HIV-1, hepatitis (A,B, and C), and measles in Romanian children.

Rudin C, Berger R, Tobler R, Nars PW, Just M, Pavic N. Rudin C, et al. Among authors: berger r. Lancet. 1990 Dec 22-29;336(8730):1592-3. doi: 10.1016/0140-6736(90)93380-8. Lancet. 1990. PMID: 1979414 No abstract available.

6

Reactogenicity and immunogenicity of a recombinant hepatitis B vaccine compared with a plasma-derived vaccine in young adults.

Just M, Berger R, Just V. Just M, et al. Among authors: berger r. Postgrad Med J. 1987;63 Suppl 2:121-3. Postgrad Med J. 1987. PMID: 3317346 Clinical Trial.

7

[Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella].

Just M, Berger R, Glück R, Wegmann A. Just M, et al. Among authors: berger r. Schweiz Med Wochenschr. 1985 Nov 30;115(48):1727-30. Schweiz Med Wochenschr. 1985. PMID: 4081704 Clinical Trial. German.

8

Interferon-alpha and synthetic peptide malaria sporozoite vaccine in non-immune adults: antibody response after 40 weeks.

Stürchler D, Zimmer G, Berger R, Etlinger H, Fernex M, Matile H, Just M. Stürchler D, et al. Among authors: berger r. Bull World Health Organ. 1990;68 Suppl(Suppl):38-41. Bull World Health Organ. 1990. PMID: 2094589 Free PMC article. Clinical Trial.

9

Effects of interferons on immune response to a synthetic peptide malaria sporozoite vaccine in non-immune adults.

Stürchler D, Berger R, Etlinger H, Fernex M, Matile H, Pink R, Schlumbom V, Just M. Stürchler D, et al. Among authors: berger r. Vaccine. 1989 Oct;7(5):457-61. doi: 10.1016/0264-410x(89)90162-x. Vaccine. 1989. PMID: 2479187 Clinical Trial.

10

Immunogenicity of a heat-treated recombinant DNA hepatitis B vaccine.

Just M, Berger R. Just M, et al. Among authors: berger r. Vaccine. 1988 Oct;6(5):399-400. doi: 10.1016/0264-410x(88)90137-5. Vaccine. 1988. PMID: 2973693 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,062 results

Search Page

Filters